CARYX | CLTAX | CARYX / CLTAX | |
Total Expense Ratio | 0.77 | 1.53 | 50% |
Annual Report Gross Expense Ratio | 0.77 | 2.09 | 37% |
Fund Existence | 11 years | 13 years | - |
Gain YTD | 12.748 | 11.765 | 108% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 1000000 | 2500 | 40,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.5B | 17.8M | 14,039% |
Annual Yield % from dividends | 2.28 | 0.02 | 13,048% |
Returns for 1 year | 10.33 | 6.44 | 160% |
Returns for 3 years | 34.93 | 13.17 | 265% |
Returns for 5 years | 11.68 | 7.14 | 163% |
Returns for 10 years | 37.19 | 26.07 | 143% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
WWMCX | 11.91 | 0.01 | +0.08% |
Westwood Quality Midcap Institutional | |||
IJPTX | 12.35 | N/A | N/A |
VY® JPMorgan Emerging Markets Equity S2 | |||
PHLAX | 36.77 | -0.05 | -0.14% |
PGIM Jennison Health Sciences A | |||
PEAPX | 34.10 | -0.11 | -0.32% |
Principal Glb Emerging Markets R3 | |||
AIVOX | 11.32 | -0.05 | -0.44% |
American Century International Opps A |